Vulvovaginal Candidiasis, Desquamative Inflammatory Vaginitis, and Atrophic Vaginitis

Sobel, Jack D.

doi:10.1002/9781118314937.ch9

Cited by 3 publications

(4 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A vaginose citolítica é desencadeada por um processo não infeccioso, em que há corrimento esbranquiçado, dispareunia, ardor genital, pH < 4,0 e piora do quadro no período pré-menstrual, o que a assemelha muito ao quadro de candidíase vulvovaginal (FERNANDES & SÁ, 2019). A vaginite inflamatória descamativa é caracterizada por um processo inflamatório intenso, que usualmente leva a desconforto genital pronunciado (SOBEL, 2022b).…”

Section: Diagnóstico Diferencialunclassified

Vulvovaginites

ALVES¹,

PAULA²,

CALIMAN³

et al. 2023

Saúde Da Mulher - Edição VIII

View full text Add to dashboard Cite

Section: Diagnóstico Diferencialunclassified

Vulvovaginites

ALVES¹,

PAULA²,

CALIMAN³

et al. 2023

Saúde Da Mulher - Edição VIII

View full text Add to dashboard Cite

“…The diagnosis of bacterial vaginosis was made when three of the four following signs were present-Amsel's criteria. 12,13 An adherent and homogenous vaginal discharge. Vaginal pH greater than 4.5.…”

Section: Whiff's Testmentioning

confidence: 99%

Prevelance, risk factors and adverse perinatal outcomes of bacterial vaginosis in pregnancy

Shetty

Menon

Rao

2021

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Bacterial Vaginosis (BV) is the most common lower genital tract syndrome in women of age group 16 to 25years.BV is a disorder of the vaginal microbial ecosystem characterized by a shift in the vaginal flora, from the normally predominant Lactobacillus species to one dominated by a mixed flora. The prevalence of BV can be around 15-30% and upto 50% in pregnancy. This study aims to study the prevalence of BV and their adverse outcomes on pregnancy.Methods: It is a Cross Sectional Study at Department of Obstetrics and Gynecology, at a tertiary care hospital, for a period of one and half year from November 2016-April 2018.Pregnant women attending antenatal clinic were enrolled after obtaining an informed consent and vaginal swab examination done. The sample size was 200.Results: The prevalence of BV in pregnant females was 18%. The major risk factors for BV in pregnancy were young age, low socioeconomic status and recent sexual activity. All patients who took treatment for BV had good outcome. Amsel criteria had low sensitivity but very high specificity(95%).Individually vaginal PH had a very high sensitivity(91.6%) when compared to the gold standard Gram stain.Conclusions: Routine screening is recommended for all pregnant women with risk factors and with symptoms. Early diagnosis and treatment in pregnant women who are asymptomatic and with no risk factors can prevent adverse outcome.

show abstract

“…Вульвовагинальный кандидоз (ВВК) -вторая по распространенности причина вагинита после БВ, которая поражает 70-75% женщин всех возрастов как минимум 1 раз и 40-45% ≥2 раза в течение жизни [16,17]. В 85-95% случаев причиной ВВК являются дрожжеподобные грибы Candida albicans, а в остальных случаях -Candida non-albicans, главным образом, C. glabrata [18].…”

Section: рис 1 факторы оказывающие влияние на вульвовагинальную экunclassified

“…Как уже отмечалось выше, в последние годы неуклонно растет распространенность ВВК и его удельный вес в структуре инфекционных поражений вульвы и влагалища достигает 30-45% [16,17]. Хотя в большинстве случаев, заболевание связано с видом Candida albicans, у 15% пациенток обнаруживаются виды Candida non-albicans (например, Candida glabrata) [18].…”

Section: изолированное антимикотическое воздействиеunclassified

A review of international and Russian scientific data on the use of polygynax for the treatment and prevention of patients with nonspecific (aerobic), vulvovaginal candidiasis, and mixed vaginitis

Кира¹,

Savicheva²

2018

Ross. vestn. akush.-ginekol.

View full text Add to dashboard Cite

The paper gives an analytical review of the results of recent researches into the etiology, diagnosis, treatment, and prevention of infectious and inflammatory diseases of the vagina and vulva. The characteristic feature of inflammatory diseases of the lower genital tract is shown to be the predominance of mixed infections, and the formation of various bacterial and bacterial-fungal associations in the vaginal biotope (associations of gram-positive, gram-negative bacteria and fungi of the genus Candida) leads to a change in the clinical picture and to the paucisymptomatic forms of the disease, which complicate diagnosis and treatment. The paper states the basic requirements for a drug for the rational therapy of vaginal and vulvar infectious and inflammatory diseases of mixed bacterial and fungal etiologies, which should have a wide range of antimicrobial activity and a non-suppressive effect on the normal vaginal microflora (lactobacilli, bifidobacteria). Polygynax is a vaginal combination drug designed in France, which meets the above requirements in composition (neomycin sulfate 35 000 IU, polymyxin B sulfate 35,000 IU, and nystatin 100,000 IU in one capsule). The paper gives the results of original investigations by both Russian and foreign authors, which have shown the high efficacy of Polygynax in the treatment of both bacterial and fungal vaginitis. The efficacy of polygynax is of value not only against C. albicans strains, but also against C. non-albicans ones resistant to other drugs. The local use of the drug prevents the development of resistance of the pathological microflora. Polygynax does not inhibit the growth of the vaginal Lactobacillus microflora. It is the drug of choice in the local treatment of vaginitis, especially when treatment should be initiated before the results of microbiological examination are available.

show abstract

Vulvovaginal Candidiasis, Desquamative Inflammatory Vaginitis, and Atrophic Vaginitis

Cited by 3 publications

References 24 publications

Vulvovaginites

Vulvovaginites

Prevelance, risk factors and adverse perinatal outcomes of bacterial vaginosis in pregnancy

A review of international and Russian scientific data on the use of polygynax for the treatment and prevention of patients with nonspecific (aerobic), vulvovaginal candidiasis, and mixed vaginitis

Contact Info

Product

Resources

About